2380P Real-world effectiveness of single agent enfortumab vedotin (EV) in patients (pts) with locally advanced or metastatic urothelial carcinoma (mUC) based on line of therapy and impact of prior platinum (plat) chemotherapy (chemo) and PD-1/PD-L1 inhibitors (PD-1/PD-L1i)

• DOI: 10.1016/j.annonc.2023.09.1029
• Publication Date: 2023-10-20T11:58:04Z
• Authors: N. Sayegh; Y. Jung Jo; G. Gebrael; N. Tripathi; B. Chigarira; A. Srivastava; B. Nordblad; E. Dal; C. Hage Chehade; B.L. Maughan; S. Gupta; N. Agarwal; U. Swami
• Keywords: Metastatic Urothelial Carcinoma